Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

The implementation of the new program of research and innovation in the European Union, Horizon 2020, has objective to improve the health and well-being of European citizens through new and more effective treatments, diagnostic imaging techniques.